Quality of informed consent: A new measure of understanding among research subjects

Journal of the National Cancer Institute

Volumn 93, Issue 2, 2001, Pages 139-147

  Joffe, Steven ^a   Cook, E Francis ^b   Cleary, Paul D ^c   Clark, Jeffrey W ^d   Weeks, Jane C ^b,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RESEARCH; CLINICAL PROTOCOL; CLINICAL STUDY; COMPREHENSION; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GOVERNMENT; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INFORMED CONSENT; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; NATIONAL HEALTH SERVICE; PATIENT ATTITUDE; PEER REVIEW; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; STANDARDIZATION;

EID: 0035900908     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.2.139     Document Type: Article

References (42)

1. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer
2. Physician response to informed consent regulations for randomized clinical trials
3. Fundamental dilemmas of the randomized clinical trial process: Results of a survey of the 1737 Eastern cooperative oncology group investigators
4. Clinical research and clinical care: Ethical problems in the "war on cancer."
5. Perceptions of cancer patients and their physicians involved in phase I trials
6. Study of cohort-specific consent and patient control in phase I cancer trials
7. The conduct of phase I-II clinical trials in children with cancer
8. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents
9. On the nature and ethics of phase I clinical trials of cancer chemotherapies
10. Ethical issues in phase I oncology research: A comparison of investigators and institutional review board chairpersons
11. Phase I pediatric oncology trials
12. When research is best therapy
13. Ethical difficulties with randomized clinical trials involving cancer patients: Examples from the field of gynecologic oncology
14. Informed consent in European multicentre randomised clinical trials-are patients really informed?
15. The last patient in a drug trial
16. Impact of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective
17. What makes clinical research ethical?
18. Toward a model of the legal doctrine of informed consent
19. Ethics of research with human subjects: Selected policies and resources
20. Recommendations guiding physicians in biomedical research involving human subjects
21. What we do and do not know about informed consent
22. Informed consent-why are its goals imperfectly realized?
23. The impact of disease severity on the informed consent process in clinical research
24. Informed consent: Study of quality of information given to participants in a clinical trial
25. Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer
26. Are research subjects really informed?
27. Informed consent for investigational chemotherapy: Patients' and physicians' perceptions
28. False hopes and best data: Consent to research and the therapeutic misconception
29. The deaconess informed consent comprehension test: An assessment tool for clinical research subjects
30. Monitoring informed consent in an oncology study posing serious risk to subjects. IRB: A review of human subjects research
31. Updating protections for human subjects involved in research
32. Clinical development of anticancer agents-a National Cancer Institute perspective
33. A simple technique for increasing cancer patients knowledge of informed consent to treatment